Log in / Register Soon
Official Education Partner of the Delhi Medicos Premier League — free question bank for every player and college
Q1 LONG ANSWER 10M ★ High-yield

Define chronic obstructive pulmonary disease. Describe chronic bronchitis and emphysema with their types, pathogenesis and morphology.

Pathology · 2nd Professional — Para-Clinical

Definition

Chronic obstructive pulmonary disease (COPD) is characterised by persistent airflow limitation that is not fully reversible and is usually progressive. It comprises chronic bronchitis and emphysema, which usually coexist.

DiseaseHow it is definedDefinition
Chronic bronchitisClinicallyA persistent productive cough for at least 3 months in each of 2 consecutive years, with other causes excluded
EmphysemaMorphologicallyPermanent enlargement of the airspaces distal to the terminal bronchiole, with destruction of their walls and without obvious fibrosis
  • The two are defined on completely different grounds — one by history, the other by anatomy — which is why one can be diagnosed at the bedside and the other cannot
  • Smoking is responsible for the great majority; in India, biomass fuel smoke from indoor cooking is a major additional cause, particularly in women who have never smoked

Chronic Bronchitis

Chronic irritation by tobacco smoke, biomass smoke, dust or pollution → hypersecretion of mucus — hypertrophy and hyperplasia of the submucosal glands in large airways and increase in goblet cells in small airways → Impaired ciliary function and squamous metaplasia → Small airway disease — inflammation, fibrosis and mucus plugging of bronchioles → Airflow obstruction, recurrent infection and eventually cor pulmonale

  • REID index — the ratio of the thickness of the mucous gland layer to the thickness of the bronchial wall between epithelium and cartilage. Normal is under 0.4; it is raised in chronic bronchitis
  • The obstruction is chiefly in the small airways, not in the large ones where the mucus is most obvious — the sputum is a marker of the disease rather than its mechanism

Emphysema — Types

TypePart of acinus affectedDistributionAssociation
Centriacinar (centrilobular)Central and proximal parts — respiratory bronchioles; distal alveoli sparedUpper lobes and apical segmentsSmoking — by far the commonest type, about 95%
Panacinar (panlobular)The whole acinus uniformly, from respiratory bronchiole to alveoliLower zones and anterior marginsAlpha-1 antitrypsin deficiency
Paraseptal (distal acinar)Distal acinus; proximal part normalAdjacent to the pleura and septa, upper lobesSpontaneous pneumothorax in young adults, from ruptured subpleural bullae
IrregularAcinus irregularly involvedAround scarsThe commonest form at autopsy but usually asymptomatic

Conditions wrongly called emphysema

  • Compensatory hyperinflation — dilatation without destruction, after lobectomy
  • Obstructive overinflation — air trapped behind a partial obstruction
  • Interstitial ("surgical") emphysema — air in the connective tissue, not in the airspaces at all
  • Senile hyperinflation — age-related alveolar duct enlargement without wall destruction

Pathogenesis of Emphysema

Protease–antiprotease imbalance → Smoking attracts neutrophils and macrophages to the alveoli → They release elastase, proteinases and matrix metalloproteinases → Smoking also causes oxidant stress, which inactivates alpha-1 antitrypsin — a "functional antitrypsin deficiency" even in people with normal genes → Unopposed proteolysis destroys elastin in alveolar walls → Loss of elastic recoil and of the radial traction that holds small airways open → Airways collapse on expiration → air trapping and airflow obstruction

  • Alpha-1 antitrypsin deficiency — the PiZZ genotype; a protease inhibitor made in the liver. Causes panacinar emphysema in the lower lobes in a young non-smoker, together with liver cirrhosis from accumulation of misfolded protein in hepatocytes (PAS-positive, diastase-resistant globules). Smoking accelerates it enormously

CLINICAL PEARL

The obstruction in emphysema is caused by loss of tethering, not by anything inside the airway. Alveolar walls normally exert radial traction that holds the small airways open. Destroy them and the airways collapse during expiration, trapping air. This is why emphysema causes obstruction despite having no mucus, no bronchospasm and no wall thickening — and why patients instinctively purse their lips to raise airway pressure and splint the airways open.

Clinical Correlation

FeaturePredominant chronic bronchitisPredominant emphysema
Nickname"blue bloater""pink puffer"
Age at presentation40–4550–75
DyspnoeaMild, lateSevere, early
Cough and sputumEarly and copiousLate and scanty
ChestNot hyperinflatedBarrel-shaped, hyperinflated
CyanosisMarkedAbsent or slight
Arterial gasesHypoxaemia and hypercapniaNear normal until late
Cor pulmonaleEarly and commonLate and uncommon
Chest radiographProminent vessels, large heartHyperinflation, flat diaphragm, small heart, bullae

Complications and Course of COPD

ComplicationMechanism
Recurrent infective exacerbationsImpaired mucociliary clearance; Haemophilus influenzae, pneumococcus, Moraxella, viruses
Respiratory failureType II (hypoxaemia with hypercapnia) in chronic bronchitis; type I in emphysema until late
Pulmonary hypertension and cor pulmonaleHypoxic vasoconstriction plus loss of the capillary bed → right ventricular hypertrophy and failure
Secondary polycythaemiaChronic hypoxaemia drives erythropoietin
PneumothoraxRupture of a bulla
Weight loss and muscle wastingIncreased work of breathing and systemic inflammation
Increased risk of lung carcinomaShared causation with smoking, and independent of it
  • Cor pulmonale is right heart failure caused by lung disease, and is the usual terminal event in chronic bronchitis

Applied Aspects

  • Spirometry is essential for diagnosis — a post-bronchodilator FEV1/FVC below 0.7 confirms irreversible obstruction and separates COPD from asthma
  • Stopping smoking is the only intervention that alters the rate of decline in FEV1; drugs relieve symptoms but do not change the trajectory
  • Long-term oxygen therapy improves survival in chronic hypoxaemia, and is one of the few treatments that does
  • Give oxygen carefully in severe COPD — in the minority who rely on hypoxic drive, uncontrolled oxygen worsens carbon dioxide retention; controlled oxygen with monitoring is the answer, and hypoxia must never be left untreated
  • COPD in India is often not smoking-related — biomass exposure, occupational dust and post-tuberculous lung damage are major contributors, and improved cooking stoves are a genuine public health measure
  • Suspect alpha-1 antitrypsin deficiency in emphysema under 45, in a non-smoker, with basal changes, or with unexplained liver disease
  • Pulmonary rehabilitation improves exercise capacity and quality of life more than any drug, and is under-used everywhere
  • Vaccination against influenza and pneumococcus reduces exacerbations and hospital admission

All questions in Respiratory Pathology

  1. Q1Define chronic obstructive pulmonary disease. Describe chronic bronchitis and emphysema with their types, pathogenesis and morphology. ★
  2. Q2Classify pneumonia. Describe the stages of lobar pneumonia and differentiate it from bronchopneumonia. ★
  3. Q3Define pulmonary hypertension and cor pulmonale. Classify pulmonary hypertension and describe its pathogenesis and morphology. ★
  4. Q4Classify carcinoma of the lung. Describe the morphology, local effects and spread of the major types. ★
  5. Q5Classify interstitial lung disease. Describe the pneumoconioses and idiopathic pulmonary fibrosis. ★
  6. SN1Describe bronchial asthma with its types, pathogenesis and morphology. ★
  7. SN2Define bronchiectasis. Describe its causes, pathogenesis and complications. ★
  8. SN3Describe acute respiratory distress syndrome with its causes, pathogenesis and morphology. ★
  9. SN4Describe lung abscess with its causes, morphology and complications. ★
  10. SN5Classify pleural effusion. Describe malignant mesothelioma and add a note on pneumothorax. ★
  11. SN6Define atelectasis. Classify it and describe its causes and consequences. ★
  12. SN7Describe sarcoidosis with its morphology, clinical features and diagnosis.

Every Pathology chapter →

Scroll to Top